[1] |
Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee[J]. J Am Acad Dermatol, 2018,78(1):148⁃155. doi: 10.1016/j.jaad.2017.08.037.
|
[2] |
Culp B, Scheinfeld N. Rosacea: a review[J]. P T, 2009,34(1):38⁃45.
|
[3] |
杨赛, 谢红付, 邓宇瑄, 等. 421例玫瑰痤疮患者临床特征分析[J]. 中华皮肤科杂志, 2016,49(2):119⁃122. doi: 10.3760/cma.j.issn.0412⁃4030.2016.02.009.
|
[4] |
Yuan X, Huang X, Wang B, et al. Relationship between rosacea and dietary factors: a multicenter retrospective case⁃control survey[J]. J Dermatol, 2019,46(3):219⁃225. doi: 10.1111/1346⁃8138.14771.
|
[5] |
中国医师协会皮肤科医师分会皮肤美容亚专业委员会. 中国玫瑰痤疮诊疗专家共识(2016)[J]. 中华皮肤科杂志, 2017,50(3):156⁃161. doi: 10.3760/cma.j.issn.0412⁃4030.2017. 03.002.
|
[6] |
Paolini JF, Mitchel YB, Reyes R, et al. Measuring flushing symptoms with extended⁃release niacin using the flushing symptom questionnaire: results from a randomised placebo⁃controlled clinical trial[J]. Int J Clin Pract, 2008,62(6):896⁃904. doi: 10.1111/j.1742⁃1241.2008.01739.x.
|
[7] |
Tan J, Liu H, Leyden JJ, et al. Reliability of clinician erythema assessment grading scale[J]. J Am Acad Dermatol, 2014,71(4):760⁃763. doi: 10.1016/j.jaad.2014.05.044.
|
[8] |
Tan J, Leoni M. Erythema of rosacea: validation of patient's self⁃assessment grading scale[J]. J Drugs Dermatol, 2015,14(8):841⁃844.
|
[9] |
Zeichner JA, Eichenfield LF, Feldman SR, et al. Quality of life in individuals with erythematotelangiectatic and papulopustular rosacea: findings from a web⁃based survey[J]. J Clin Aesthet Dermatol, 2018,11(2): 47⁃52.
|
[10] |
Alexis AF, Callender VD, Baldwin HE, et al. Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: review and clinical practice experience[J]. J Am Acad Dermatol, 2019,80(6):1722⁃1729.e7. doi: 10.1016/j.jaad.2018.08.049.
|
[11] |
汪犇, 李吉, 杨赛, 等. 1 090例玫瑰痤疮患者临床特征分析及玫瑰痤疮新诊断标准探讨[J]. 中华皮肤科杂志, 2017,50(3):162⁃166. doi: 10.3760/cma.j.issn.0412⁃4030.2017.03.003.
|
[12] |
Bae YI, Yun SJ, Lee JB, et al. Clinical evaluation of 168 Korean patients with rosacea: the sun exposure correlates with the erythematotelangiectatic subtype[J]. Ann Dermatol, 2009,21(3):243⁃249. doi: 10.5021/ad.2009.21.3.243.
|
[13] |
Scharschmidt TC, Yost JM, Truong SV, et al. Neurogenic rosacea: a distinct clinical subtype requiring a modified approach to treatment[J]. Arch Dermatol, 2011,147(1):123⁃126. doi: 10.1001/archdermatol.2010.413.
|
[14] |
Schaller M, Almeida L, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel[J]. Br J Dermatol, 2019. doi: 10.1111/bjd.18420.
|
[15] |
Anzengruber F, Czernielewski J, Conrad C, et al. Swiss S1 guideline for the treatment of rosacea[J]. J Eur Acad Dermatol Venereol, 2017,31(11):1775⁃1791. doi: 10.1111/jdv.14349.
|
[16] |
Egeberg A, Hansen PR, Gislason GH, et al. Patients with rosacea have increased risk of depression and anxiety disorders: a Danish nationwide cohort study[J]. Dermatology, 2016,232(2):208⁃213. doi: 10.1159/000444082.
|